Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression.

Literature DB >> 23293563

Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression.

Abstract

Treatment regimens for Crohn's disease and ulcerative colitis increase susceptibility to infections, many of which can be prevented by vaccinations. Increased awareness concerning vaccine-preventable diseases has led to several studies investigating the immunologic responses to vaccines in immunosuppressed patients with inflammatory bowel disease. This review provides an overview of the evidence-based rationale for currently accepted recommendations regarding the use of both inactivated and live vaccines in this unique population.

Entities: Disease Species

Keywords: Inflammatory bowel disease; immunization; infection; pertussis; pneumococcal vaccine; vaccination

Year: 2012 PMID： 23293563 PMCID： PMC3533208

Source DB: PubMed Journal: Gastroenterol Hepatol (N Y) ISSN： 1554-7914

70 in total

1. Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate.

Authors: P Ostuni; C Botsios; L Punzi; P Sfriso; S Todesco
Journal: Ann Rheum Dis Date: 2003-07 Impact factor: 19.103

2. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: J Erin Staples; Mark Gershman; Marc Fischer
Journal: MMWR Recomm Rep Date: 2010-07-30

3. Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease.

Authors: H J Nielsen; T Mortensen; M Holten-Andersen; N Brünner; S Sørensen; J Rask-Madsen
Journal: Scand J Gastroenterol Date: 2001-03 Impact factor: 2.423

4. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.

Authors: C Loras; J P Gisbert; M Mínguez; O Merino; L Bujanda; C Saro; E Domenech; J Barrio; M Andreu; I Ordás; L Vida; G Bastida; F González-Huix; M Piqueras; D Ginard; X Calvet; A Gutiérrez; A Abad; M Torres; J Panés; M Chaparro; I Pascual; M Rodriguez-Carballeira; F Fernández-Bañares; J M Viver; M Esteve
Journal: Gut Date: 2010-06-24 Impact factor: 23.059

5. Immunogenecity of hepatitis A vaccine in pediatric patients with inflammatory bowel disease.

Authors: Andrzej Radzikowski; Aleksandra Banaszkiewicz; Izabella Łazowska-Przeorek; Urszula Grzybowska-Chlebowczyk; Halina Woś; Tomasz Pytrus; Barbara Iwańczak; Kinga Kowalska-Duplaga; Krzysztof Fyderek; Agnieszka Gawrońska; Katarzyna Karolewska-Bochenek; Maria Kotowska; Piotr Albrecht
Journal: Inflamm Bowel Dis Date: 2010-09-03 Impact factor: 5.325

Review 6. Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy.

Authors: Ying Lu; Athos Bousvaros
Journal: J Pediatr Gastroenterol Nutr Date: 2010-05 Impact factor: 2.839

7. [Adequate rate of response to hepatitis B virus vaccination in patients with inflammatory bowel disease].

Authors: Luis Vida Pérez; Federico Gómez Camacho; Valle García Sánchez; Eva M A Iglesias Flores; Laura Castillo Molina; Antonio Cerezo Ruiz; Luis Casáis Juanena; Juan Francisco De Dios Vega
Journal: Med Clin (Barc) Date: 2009-03-09 Impact factor: 1.725

8. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: J C Watson; S C Hadler; C A Dykewicz; S Reef; L Phillips
Journal: MMWR Recomm Rep Date: 1998-05-22

9. [Opportunistic infections in patients with inflammatory bowel disease undergoing immunosuppressive therapy].

Authors: I Bernal; E Domènech; E García-Planella; E Cabré; M A Gassull
Journal: Gastroenterol Hepatol Date: 2003-01 Impact factor: 2.102

Review 10. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics.

Authors: Gil Y Melmed
Journal: Inflamm Bowel Dis Date: 2009-09 Impact factor: 5.325

9 in total

1. Health concerns associated with travelling with inflammatory bowel disease (IBD): a questionnaire survey.

Authors: Varun Philip; Anet Soubieres; Andrew Poullis
Journal: Clin Med (Lond) Date: 2018-08 Impact factor: 2.659

2. Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.

Authors: Adam M Berg; Aamir N Dam; Francis A Farraye
Journal: Gastroenterol Hepatol (N Y) Date: 2013-12

3. Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.

Authors: Hung-Viet Pham; Imran Hasan; Natalia Udaltsova; Kathy Pham; Oren Abramson; Mary Anne Armstrong; Debbie Postlethwaite; Dan Li
Journal: Dig Dis Sci Date: 2017-08-23 Impact factor: 3.199

4. Hepatitis B vaccination in patients with inflammatory bowel disease.

Authors: Ruwaida Ben Musa; Anuhya Gampa; Sanjib Basu; Ali Keshavarzian; Garth Swanson; Michael Brown; Rana Abraham; Keith Bruninga; John Losurdo; Mark DeMeo; Sohrab Mobarhan; David Shapiro; Ece Mutlu
Journal: World J Gastroenterol Date: 2014-11-07 Impact factor: 5.742

9. Insufficient Knowledge and Vaccination Practice of Inflammatory Bowel Disease Patients in the People's Republic of China.

Authors: Shuyi Feng; Saizheng Lin; Lingling Ma; Song Xu; Yan Chen
Journal: Patient Prefer Adherence Date: 2020-08-24 Impact factor: 2.711